(+)-(S)-2-(p-tolylsulfinyl)cyclohexa-2,5-diene-1,4-dione

ID: ALA4174979

PubChem CID: 10944718

Max Phase: Preclinical

Molecular Formula: C13H10O3S

Molecular Weight: 246.29

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc([S@+]([O-])C2=CC(=O)C=CC2=O)cc1

Standard InChI:  InChI=1S/C13H10O3S/c1-9-2-5-11(6-3-9)17(16)13-8-10(14)4-7-12(13)15/h2-8H,1H3/t17-/m0/s1

Standard InChI Key:  QNGGYUIDBHXGGO-KRWDZBQOSA-N

Molfile:  

     RDKit          2D

 17 18  0  0  0  0  0  0  0  0999 V2000
   28.5398   -2.9269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5398   -3.7519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2524   -4.1582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9651   -3.7519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.9651   -2.9269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2524   -2.5082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.2524   -1.6832    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.2524   -4.9832    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.6813   -2.5145    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   31.3951   -2.9311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.6837   -1.6895    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.3911   -3.7572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1042   -4.1696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8172   -3.7612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8170   -2.9319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1075   -2.5191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5316   -4.1728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  3  8  2  0
  5  9  1  0
  9 10  1  1
  9 11  1  0
 10 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 10  1  0
 14 17  1  0
M  CHG  2   9   1  11  -1
M  END

Alternative Forms

Associated Targets(Human)

Mahlavu (271 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hep 3B2 (2332 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Huh-7 (12904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SNU-475 (119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 246.29Molecular Weight (Monoisotopic): 246.0351AlogP: 1.69#Rotatable Bonds: 2
Polar Surface Area: 57.20Molecular Species: HBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.17CX LogD: 2.17
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.59Np Likeness Score: 0.34

References

1. Kahraman DC, Hanquet G, Jeanmart L, Lanners S, Šramel P, Boháč A, Cetin-Atalay R..  (2017)  Quinoides and VEGFR2 TKIs influence the fate of hepatocellular carcinoma and its cancer stem cells.,  (1): [PMID:30108693] [10.1039/C6MD00392C]

Source